HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oestrogenic activity of parabens in MCF7 human breast cancer cells.

Abstract
Parabens (4-hydroxybenzoic acid esters) have been recently reported to have oestrogenic activity in yeast cells and animal models. Since the human population is exposed to parabens through their widespread use as preservatives in foods, pharmaceuticals and cosmetics, we have investigated here whether oestrogenic activity of these compounds can also be detected in oestrogen-sensitive human cells. We report on the oestrogenic effects of four parabens (methylparaben, ethylparaben, n-propylparaben, n-butylparaben) in oestrogen-dependent MCF7 human breast cancer cells. Competitive inhibition of [3H]oestradiol binding to MCF7 cell oestrogen receptors could be detected at 1,000,000-fold molar excess of n-butylparaben (86%), n-propylparaben (77%), ethyl-paraben (54%) and methylparaben (21%). At concentrations of 10(-6)M and above, parabens were are able to increase expression of both transfected (ERE-CAT reporter gene) and endogenous (pS2) oestrogen-regulated genes in these cells. They could also increase proliferation of the cells in monolayer culture, which could be inhibited by the antiestrogen ICI 182,780, indicating that the effects were mediated through the oestrogen receptor. However, no antagonist activity of parabens could be detected on regulation of cell proliferation by 17 beta-oestradiol at 10(-10)M. Molecular modelling has indicated the mode by which paraben molecules can bind into the ligand binding pocket of the crystal structure of the ligand binding domain (LBD) of the oestrogen receptor alpha (ERalpha) in place of 17beta-oestradiol; it has furthermore shown that two paraben molecules can bind simultaneously in a mode in which their phenolic hydroxyl groups bind similarly to those of the meso-hexoestrol molecule. Future work will need to address the extent to which parabens can accumulate in hormonally sensitive tissues and also the extent to which their weak oestrogenic activity can add to the more general environmental oestrogen problem.
AuthorsJ R Byford, L E Shaw, M G B Drew, G S Pope, M J Sauer, P D Darbre
JournalThe Journal of steroid biochemistry and molecular biology (J Steroid Biochem Mol Biol) Vol. 80 Issue 1 Pg. 49-60 (Jan 2002) ISSN: 0960-0760 [Print] England
PMID11867263 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Estrogen Antagonists
  • Estrogen Receptor alpha
  • Estrogens
  • Food Preservatives
  • Ligands
  • Parabens
  • Proteins
  • Receptors, Estrogen
  • TFF1 protein, human
  • Trefoil Factor-1
  • Tumor Suppressor Proteins
  • Fulvestrant
  • Estradiol
Topics
  • Animals
  • Binding Sites
  • Breast Neoplasms (metabolism)
  • Estradiol (analogs & derivatives, pharmacology)
  • Estrogen Antagonists (pharmacology)
  • Estrogen Receptor alpha
  • Estrogens (chemistry, metabolism)
  • Female
  • Food Preservatives (chemistry, metabolism)
  • Fulvestrant
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Structure
  • Parabens (chemistry, metabolism)
  • Protein Binding
  • Proteins (genetics, metabolism)
  • Receptors, Estrogen (chemistry, metabolism)
  • Trefoil Factor-1
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: